Table 6.
Course of cardiorespiratory variables during the recovery phase
Variable | Group | Trial | Time (minutes’ seconds”) | Cumulative AUC | Intra-groupp-value | Inter-group · Time−1 | |||
---|---|---|---|---|---|---|---|---|---|
0′00′′ | 1′30′′ | 3′00′′ | 4′30′′ | ||||||
Lactate (mmol/L) | DHA | Baseline | 12.0±3.2 | 12.4±1.8 | 11.8±1.7 | 11.3±1.4 | 880.6±100.4 | } p = 0.841 | } p = 0.694 |
Post | 11.2±1.9 | 12.1±1.9 | 12.0±2.0 | 11.2±2.3 | 874.5±141.6 | ||||
PLA | Baseline | 11.4±1.7 | 12.2±2.0 | 12.0±1.7 | 11.5±2.1 | 908.1±157.2 | } p = 0.718 | ||
Post | 11.3±2.4 | 12.4±1.6 | 12.2±1.8 | 12.1±1.9 | 918.4±127.0 | ||||
VO2 (ml/min) | DHA | Baseline | 3662±425 | 2122±451 | 1767±363 | 1556±285 | 584,825±91,516 | } p = 0.034* | } p = 0.136 |
Post | 3662±549 | 2248±421 | 1960±365 | 1750±374 | 622,230±97,050 | ||||
PLA | Baseline | 3629±403 | 2154±336 | 1791±287 | 1654±282 | 592,765±75,399 | } p = 0.920 | ||
Post | 3600±432 | 2142±427 | 1800±407 | 1726±399 | 594,396±100,112 | ||||
HR (bpm) | DHA | Baseline | 184±9 | 158±12 | 158±12 | 141±12 | 41,010±2,778 | } p = 0.001* | } p = 0.005* |
Post | 182±9 | 151±12 | 130±11 | 122±13 | 38,955±2,719 | ||||
PLA | Baseline | 181±10 | 155±13 | 137±12 | 137±12 | 40,259±3,135 | } p = 0.024* | ||
Post | 180±10 | 152±12 | 134±11 | 128±9 | 39,535±2,682 |
Values are presented as mean ± standard deviation (SD). Intra-group and inter-group analysis corresponds to the cumulative area under the curve (AUC) * p <0.05